Please login to the form below

Not currently logged in
Email:
Password:

INC Research hires former Pfizer senior director

Beatrice Setnik joins CRO as VP, clinical pharmacology
INC Research Beatrice Setnik

INC Research has appointed former Pfizer senior director Dr Beatrice Setnik as VP, clinical pharmacology.

Setnik had been with pharma giant Pfizer since 2008 serving as senior director, medical development for the company's neuroscience business.

Prior to this she spent several years at Kendle in senior research positions.

In her new role at the contract research organisation (CRO) INC Research she will support the company's early phase business unit, providing scientific direction on matters related to abuse liability for investigational products.

Dr Pierre Geoffroy, VP, early phase at INC Research commented on Dr Setnik's suitability for the role.

"Dr Setnik's extensive knowledge and experience in the area of human abuse liability assessment and risk evaluation, as well as in CNS drug development, clinical trial design and strategic lifecycle management, will be instrumental in furthering the development of our abuse potential capabilities and new scientific growth strategies for early phase clinical research,” said Dr Geoffroy.

13th February 2014

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...
How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...